<!-- Main Content Component for Molecular Tumor Testing Page -->
<div class="molecular-content">
    <!-- Introduction Card -->
    <div class="intro-card">
        <p>Biomarkers are measurable indicators found in the body that can provide valuable information about a person's health status, disease risk, or response to treatment. In cancer care, biomarkers can be molecules, genes, or characteristics that help doctors understand the unique features of a tumor.</p>
    </div>

    <div class="main-content">
        <!-- Introduction Section -->
        <section id="introduction" class="content-section biomarkers-section">
            <div class="section-header">
                <div class="icon-wrapper">
                    <i class="fas fa-dna"></i>
                </div>
                <h2 class="section-title">Introduction to Biomarkers</h2>
            </div>
            
            <div class="section-content">
                <div class="info-card">
                    <div class="card-header">
                        <div class="card-icon">
                            <i class="fas fa-question-circle"></i>
                        </div>
                        <div class="card-title">
                            <h3>What are Biomarkers?</h3>
                            <p>Key components for personalized medicine</p>
                        </div>
                    </div>
                    
                    <p>Biomarkers are referred to as any substance, structure or process that can be analyzed in the body and helps in predicting disease. Biomarkers have a crucial role in the early detection, diagnosis, and management of treatment for major diseases like cancer and heart diseases.</p>
                    
                    <p>Biomarkers can include:</p>
                    <ul class="bullet-list">
                        <li>Genetic mutations or alterations in DNA</li>
                        <li>Proteins or enzymes produced by cancer cells</li>
                        <li>Patterns of gene expression</li>
                        <li>Specific molecules found in blood, tissue, or other body fluids</li>
                    </ul>
                </div>
            </div>
        </section>
    
    <!-- Importance Section -->
    <section id="importance" class="content-section importance-section">
        <div class="section-header">
            <div class="icon-wrapper">
                <i class="fas fa-exclamation-circle"></i>
            </div>
            <h2 class="section-title">Importance for LMS Patients</h2>
        </div>
        
        <div class="section-content">
            <p>For leiomyosarcoma (LMS) patients, molecular tumor testing can provide critical insights that may influence treatment decisions and access to clinical trials. As a rare cancer, LMS treatment can benefit significantly from a personalized approach guided by molecular testing.</p>
            
            <div class="two-column">
                <div class="column">
                    <div class="info-card">
                        <div class="card-header">
                            <div class="card-icon">
                                <i class="fas fa-check-circle"></i>
                            </div>
                            <div class="card-title">
                                <h3>Benefits of Molecular Testing</h3>
                                <p>Why testing matters for LMS patients</p>
                            </div>
                        </div>
                        
                        <ul class="bullet-list">
                            <li>Identify potential targeted therapy options</li>
                            <li>Determine eligibility for clinical trials</li>
                            <li>Better understand tumor behavior and prognosis</li>
                            <li>Guide treatment decisions based on tumor characteristics</li>
                            <li>Monitor treatment response and detect recurrence</li>
                        </ul>
                    </div>
                </div>
                
                <div class="column">
                    <div class="testimonial-card">
                        <i class="fas fa-quote-left"></i>
                        <p>"Molecular testing revealed a specific mutation in my tumor that made me eligible for a targeted therapy clinical trial. This personalized approach has given me hope and more treatment options."</p>
                        <div class="testimonial-author">- LMS Patient, Denver Support Group</div>
                    </div>
                </div>
            </div>
            
            <div class="denver-highlight">
                <div class="denver-icon">
                    <i class="fas fa-map-marker-alt"></i>
                </div>
                <div class="denver-content">
                    <h3>Denver Molecular Testing Centers</h3>
                    <p>Denver residents have access to several advanced molecular testing facilities, including the University of Colorado Cancer Center and specialized laboratories that work with oncologists throughout the region.</p>
                    <a href="#denver-testing" class="cta-link">Learn about Denver testing options <i class="fas fa-arrow-right"></i></a>
                </div>
            </div>
        </div>
    </section>
    
    <!-- Testing Types Section -->
    <section id="testing-types" class="content-section testing-section">
        <div class="section-header">
            <div class="icon-wrapper">
                <i class="fas fa-vial"></i>
            </div>
            <h2 class="section-title">Types of Molecular Testing</h2>
        </div>
        
        <div class="section-content">
            <p>Several types of molecular testing can be used to analyze tumor samples and identify important biomarkers in LMS:</p>
            
            <div class="cards-grid">
                <div class="info-card">
                    <div class="card-header">
                        <div class="card-icon">
                            <i class="fas fa-dna"></i>
                        </div>
                        <div class="card-title">
                            <h3>Next-Generation Sequencing (NGS)</h3>
                            <p>Comprehensive genetic analysis</p>
                        </div>
                    </div>
                    <p>Analyzes multiple genes simultaneously to identify mutations, amplifications, deletions, and other genetic alterations that may drive cancer growth. This technology can sequence entire genomes or targeted panels of genes relevant to LMS.</p>
                    <div class="card-footer">
                        <span class="technique-badge">Advanced Technique</span>
                    </div>
                </div>
                
                <div class="info-card">
                    <div class="card-header">
                        <div class="card-icon">
                            <i class="fas fa-microscope"></i>
                        </div>
                        <div class="card-title">
                            <h3>Immunohistochemistry (IHC)</h3>
                            <p>Protein detection method</p>
                        </div>
                    </div>
                    <p>Uses antibodies to detect specific proteins in tissue samples, helping to identify biomarkers that may be targets for therapy or indicators of prognosis. This technique can visualize protein expression patterns in tumor cells.</p>
                    <div class="card-footer">
                        <span class="technique-badge">Standard Technique</span>
                    </div>
                </div>
                
                <div class="info-card">
                    <div class="card-header">
                        <div class="card-icon">
                            <i class="fas fa-chart-bar"></i>
                        </div>
                        <div class="card-title">
                            <h3>Gene Expression Profiling</h3>
                            <p>Activity measurement</p>
                        </div>
                    </div>
                    <p>Measures the activity levels of multiple genes to create a molecular "signature" that can help predict tumor behavior and response to treatment. This approach analyzes which genes are actively being transcribed in tumor cells.</p>
                    <div class="card-footer">
                        <span class="technique-badge">Advanced Technique</span>
                    </div>
                </div>
                
                <div class="info-card">
                    <div class="card-header">
                        <div class="card-icon">
                            <i class="fas fa-tint"></i>
                        </div>
                        <div class="card-title">
                            <h3>Liquid Biopsy</h3>
                            <p>Non-invasive blood testing</p>
                        </div>
                    </div>
                    <p>Analyzes circulating tumor DNA (ctDNA) in blood samples to monitor treatment response, detect recurrence, or identify genetic alterations without invasive tissue sampling. This emerging approach offers a less invasive alternative to traditional biopsies.</p>
                    <div class="card-footer">
                        <span class="technique-badge">Emerging Technique</span>
                    </div>
                </div>
            </div>
            
            <div class="note-box">
                <p><strong>Note:</strong> The availability of these testing methods may vary by location. Discuss with your oncologist which tests are appropriate for your specific situation.</p>
            </div>
        </div>
    </section>
    
    <!-- Partnerships Section -->
    <section id="partnerships" class="content-section partnerships-section">
        <div class="section-header">
            <div class="icon-wrapper">
                <i class="fas fa-handshake"></i>
            </div>
            <h2 class="section-title">Research Partnerships</h2>
        </div>
        
        <div class="section-content">
            <p>NLMSF has established partnerships with leading organizations to improve access to molecular testing and targeted therapies for LMS patients.</p>
        </div>
    </section>
    
    <!-- Target Cancer Foundation Section -->
    <section id="target-cancer" class="content-section target-cancer-section">
        <div class="section-header">
            <div class="icon-wrapper">
                <i class="fas fa-bullseye"></i>
            </div>
            <h2 class="section-title">Target Cancer Foundation</h2>
        </div>
        
        <div class="section-content">
            <div class="info-card">
                <div class="card-header">
                    <div class="card-icon">
                        <i class="fas fa-handshake"></i>
                    </div>
                    <div class="card-title">
                        <h3>Collaborative Partnership</h3>
                        <p>Supporting LMS research</p>
                    </div>
                </div>
                
                <p>NLMSF has established a proactive collaborative partnership with Target Cancer Foundation on behalf of the LMS Patient community. This foundation is dedicated to supporting rare cancer research and improving access to precision medicine for patients with rare and understudied cancers.</p>
                
                <div class="partnership-links">
                    <a href="https://targetcancerfoundation.org/track" target="_blank" class="external-link">
                        <i class="fas fa-external-link-alt"></i>
                        Visit Target Cancer Foundation Website
                    </a>
                </div>
            </div>
            
            <!-- TRACK Trial Subsection -->
            <div id="track-trial" class="trial-box">
                <div class="trial-header">
                    <i class="fas fa-flask"></i>
                    <h3>TRACK Trial</h3>
                </div>
                
                <p>An open label, non-randomized, multi-center, pragmatic study that aims to establish whether patients with rare tumors can benefit from matched molecular therapy as dictated by their next-generation sequencing (NGS) results.</p>
                
                <div class="feature-list">
                    <h4>Key Features:</h4>
                    <ul class="bullet-list">
                        <li>Remote consent and participation approach</li>
                        <li>Available for all patients with rare tumors within the United States</li>
                        <li>Traditional, site-based patient consenting also available</li>
                    </ul>
                </div>
                
                <div class="resource-links">
                    <h4>Resources:</h4>
                    <div class="links-grid">
                        <a href="https://us02web.zoom.us/…/M23F43Rc0dz5vlKwyx95xxzFbePFi…" target="_blank" class="resource-link">
                            <i class="fas fa-video"></i>
                            <span>TRACK Trial Webinar</span>
                        </a>
                        
                        <a href="https://www.businesswire.com/news/home/20200930005492/en/TargetCancer-Foundation-Announces-First-Patients-Enrolled-in-TRACK-Study-to-Research-Genomic-Testing-in-People-with-Rare-Cancers-Supported-by-Bayer" target="_blank" class="resource-link">
                            <i class="fas fa-newspaper"></i>
                            <span>2020 Announcement</span>
                        </a>
                        
                        <a href="https://clinicaltrials.gov/ct2/show/NCT04504604" target="_blank" class="resource-link">
                            <i class="fas fa-clipboard-list"></i>
                            <span>Clinical Trials.gov</span>
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </section>
    
    <!-- Perthera Section -->
    <section id="perthera" class="content-section partnership-section">
        <h3 class="subsection-title">
            <i class="fas fa-project-diagram"></i>
            Perthera
        </h3>
        <div class="content-block">
            <p>Matching Patients to Optimal Therapies * Intelligence for Optimum Outcomes</p>
            
            <div class="partnership-card">
                <div class="partnership-logo">
                    <i class="fas fa-project-diagram"></i>
                </div>
                <div class="partnership-info">
                    <h4 class="partnership-name">Perthera</h4>
                    <p class="partnership-description">Provides precision oncology services that help match patients to optimal therapies based on molecular testing results.</p>
                    <a href="https://perthera.com/" target="_blank" class="external-link">
                        <i class="fas fa-external-link-alt"></i>
                        Visit Website
                    </a>
                </div>
            </div>
            
            <div class="feature-list">
                <h5>Key Features:</h5>
                <ul class="bullet-list purple">
                    <li>Precision Oncology services at no cost to patients or oncologists</li>
                    <li>Clinical coordination, AI and data analytics</li>
                    <li>Molecular tumor board</li>
                    <li>Report delivery included in concierge services</li>
                    <li>Less than 3 days average turnaround time</li>
                    <li>HIPAA compliant patient data protection</li>
                </ul>
            </div>
            
            <div class="resource-links">
                <h5>Resources:</h5>
                <ul class="link-list">
                    <li>
                        <a href="https://perthera.com/contact-nlmsf-perthera/" target="_blank" class="resource-link">
                            <i class="fas fa-info-circle"></i>
                            NLMSF-Perthera Information
                        </a>
                    </li>
                    <li>
                        <a href="https://bit.ly/3eczOxR" target="_blank" class="resource-link">
                            <i class="fas fa-file-pdf"></i>
                            Patient Pamphlet
                        </a>
                    </li>
                    <li>
                        <a href="https://bit.ly/2TzCBHS" target="_blank" class="resource-link">
                            <i class="fas fa-file-alt"></i>
                            Patient Take-Home
                        </a>
                    </li>
                </ul>
            </div>
            
            <!-- FAQ Subsection -->
            <div id="perthera-faq" class="subsection faq-section">
                <h4 class="subsection-title">Frequently Asked Questions</h4>
                
                <div class="faq-list">
                    <div class="faq-item">
                        <div class="faq-question">
                            <i class="fas fa-question-circle"></i>
                            <h5>What lab does the testing? How many mutations do they test for?</h5>
                        </div>
                        <div class="faq-answer">
                            <p>Perthera is not a Lab. We are Lab agnostic and will use the ordering Oncologist's preferred Lab or one of our own. The ordering physician determines how many panels/mutations they would like us to test. Lab testing is put through a patient's insurance, often with no balance billing.</p>
                        </div>
                    </div>
                    
                    <div class="faq-item">
                        <div class="faq-question">
                            <i class="fas fa-question-circle"></i>
                            <h5>How much does it cost?</h5>
                        </div>
                        <div class="faq-answer">
                            <p>Perthera delivers our Precision Oncology services at no cost to patients or oncologists.</p>
                        </div>
                    </div>
                    
                    <div class="faq-item">
                        <div class="faq-question">
                            <i class="fas fa-question-circle"></i>
                            <h5>Is the patient's data confidential or do they sell it?</h5>
                        </div>
                        <div class="faq-answer">
                            <p>We fully comply with all HIPAA requirements and maintain strict confidentiality with all patient data.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>
    
    <!-- Denver Testing Section -->
    <section id="denver-testing" class="content-section denver-section">
        <h2 class="section-title">
            <i class="fas fa-map-marker-alt"></i>
            Denver Molecular Testing Resources
        </h2>
        <div class="content-block">
            <p>Denver residents have access to several advanced molecular testing facilities and specialists who can guide you through the process.</p>
            
            <div class="cards-grid">
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-hospital"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">University of Colorado Cancer Center</h3>
                        <p class="resource-card-description">Offers comprehensive molecular testing services and has expertise in rare cancers including leiomyosarcoma.</p>
                        <a href="#" class="resource-card-link">Learn More</a>
                    </div>
                </div>
                
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-user-md"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">Denver Sarcoma Specialists</h3>
                        <p class="resource-card-description">Connect with sarcoma specialists in Denver who can help determine the right molecular testing for your specific case.</p>
                        <a href="#" class="resource-card-link">Find a Specialist</a>
                    </div>
                </div>
                
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-users"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">Denver Sarcoma Support Group</h3>
                        <p class="resource-card-description">Connect with other sarcoma patients who have undergone molecular testing and learn from their experiences.</p>
                        <a href="#" class="resource-card-link">Join the Group</a>
                    </div>
                </div>
            </div>
            
            <div class="cta-panel">
                <h3 class="cta-title">Need Help with Molecular Testing in Denver?</h3>
                <p class="cta-text">Our patient navigators can help connect you with the right resources and specialists in the Denver area.</p>
                <a href="#" class="cta-button">Contact a Patient Navigator</a>
            </div>
        </div>
    </section>
    
    <!-- Next Steps Section -->
    <section id="next-steps" class="content-section">
        <h2 class="section-title">
            <i class="fas fa-arrow-right"></i>
            Next Steps
        </h2>
        <div class="content-block">
            <p>If you're considering molecular testing for your leiomyosarcoma, here are some recommended steps:</p>
            
            <div class="steps-list">
                <div class="step-item">
                    <div class="step-number">1</div>
                    <div class="step-content">
                        <h3 class="step-title">Discuss with Your Oncologist</h3>
                        <p>Talk to your oncologist about the potential benefits of molecular testing for your specific situation.</p>
                    </div>
                </div>
                
                <div class="step-item">
                    <div class="step-number">2</div>
                    <div class="step-content">
                        <h3 class="step-title">Explore Testing Options</h3>
                        <p>Research the different types of molecular testing available and which might be most appropriate for your case.</p>
                    </div>
                </div>
                
                <div class="step-item">
                    <div class="step-number">3</div>
                    <div class="step-content">
                        <h3 class="step-title">Check Insurance Coverage</h3>
                        <p>Contact your insurance provider to understand coverage for molecular testing and any potential out-of-pocket costs.</p>
                    </div>
                </div>
                
                <div class="step-item">
                    <div class="step-number">4</div>
                    <div class="step-content">
                        <h3 class="step-title">Consider Clinical Trials</h3>
                        <p>Explore clinical trials like the TRACK Trial that may provide access to molecular testing and targeted therapies.</p>
                    </div>
                </div>
                
                <div class="step-item">
                    <div class="step-number">5</div>
                    <div class="step-content">
                        <h3 class="step-title">Connect with Resources</h3>
                        <p>Reach out to NLMSF, Target Cancer Foundation, or Perthera for additional support and guidance.</p>
                    </div>
                </div>
            </div>
        </div>
    </section>
    
    <!-- Resources Section -->
    <section id="resources" class="content-section">
        <h2 class="section-title">
            <i class="fas fa-book"></i>
            Additional Resources
        </h2>
        <div class="content-block">
            <p>Explore these additional resources to learn more about molecular testing and precision medicine for leiomyosarcoma:</p>
            
            <div class="resources-grid">
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-file-pdf"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">Molecular Testing Guide</h3>
                        <p class="resource-card-description">A comprehensive guide to understanding molecular testing for sarcoma patients.</p>
                        <a href="#" class="resource-card-link">Download PDF</a>
                    </div>
                </div>
                
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-video"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">Webinar: Precision Medicine for LMS</h3>
                        <p class="resource-card-description">An educational webinar featuring experts discussing the latest advances in precision medicine for LMS.</p>
                        <a href="#" class="resource-card-link">Watch Webinar</a>
                    </div>
                </div>
                
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-clipboard-list"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">Questions to Ask Your Doctor</h3>
                        <p class="resource-card-description">A list of important questions to ask your healthcare team about molecular testing.</p>
                        <a href="#" class="resource-card-link">View Questions</a>
                    </div>
                </div>
                
                <div class="resource-card">
                    <div class="resource-card-icon">
                        <i class="fas fa-flask"></i>
                    </div>
                    <div class="resource-card-content">
                        <h3 class="resource-card-title">LMS Biomarker Research</h3>
                        <p class="resource-card-description">Latest research on biomarkers and molecular targets in leiomyosarcoma.</p>
                        <a href="#" class="resource-card-link">Read Research</a>
                    </div>
                </div>
            </div>
        </div>
    </section>
    
    <!-- Telemedicine Section -->
    <section class="telemedicine-section">
        <h2>
            <i class="fas fa-video"></i>
            Telemedicine Clinics
        </h2>
        
        <div class="clinic-card">
            <h3 class="clinic-name">Virtual Sarcoma Clinic</h3>
            <div class="clinic-location">
                <i class="fas fa-globe"></i>
                <span>Serving: Nationwide</span>
            </div>
            <p class="clinic-description">
                Access expert sarcoma care from anywhere in the United States through virtual consultations with specialized oncologists.
            </p>
        </div>
        
        <div class="clinic-card">
            <h3 class="clinic-name">Sarcoma Telehealth Institute</h3>
            <div class="clinic-location">
                <i class="fas fa-globe"></i>
                <span>Serving: West Coast</span>
            </div>
            <p class="clinic-description">
                Specialized in providing telehealth services for sarcoma patients with a focus on molecular testing and precision medicine.
            </p>
        </div>
    </section>
    
    <!-- Virtual Second Opinion Section -->
    <section class="virtual-opinion-section">
        <h2>
            <i class="fas fa-file-medical"></i>
            Virtual Second Opinion Resources
        </h2>
        
        <p class="virtual-opinion-intro">
            Getting a second opinion at a sarcoma center is crucial. Many hospitals now offer virtual second opinions, making it easier to access expert opinions without the need for travel.
        </p>
        
        <div class="opinion-service">
            <h3 class="opinion-service-name">Sarcoma Second Opinion Service</h3>
            <p class="opinion-service-description">Expert reviews of your medical records, no travel required.</p>
        </div>
        
        <div class="opinion-service">
            <h3 class="opinion-service-name">Cancer eConsults</h3>
            <p class="opinion-service-description">Virtual consultations with top oncologists nationwide.</p>
            <a href="#" class="external-link">
                <i class="fas fa-external-link-alt"></i>
                Learn More
            </a>
        </div>
    </section>
</div>
